# clm_64E8125CC2B5

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 3,500,000,000 United States dollar  
valid_from: 2024-06-30  
valid_to: 2024-09-30  
published: 2024-08-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_EF9F40E4249B  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 3,500,000,000 United States dollar", as of 2024-06-30 (until 2024-09-30). Claim clm_64E8125CC2B5, https://asof.is/claim/clm_64E8125CC2B5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2024, filed 2024-08-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000162828024034715/0001628280-24-034715-index.htm (primary, SEC EDGAR 10-Q Q2 FY2024, published 2024-08-05)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 3,992,000,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_64E8125CC2B5](/claim/clm_64E8125CC2B5.md) | [clm_DD2E2358C2C5](/claim/clm_DD2E2358C2C5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.